Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Pinar O. Eser"'
Autor:
David A. Barbie, Raphael Bueno, Cloud P. Paweletz, Rizwan Romee, Michael Y. Tolstorukov, Juan J. Miret, Pasi A. Jänne, Eric L. Smith, Neil Lineberry, Alexander Parent, Richard C. Gregory, Vicky A. Appleman, Adnan O. Abu-Yousif, William G. Richards, Assunta De Rienzo, Marina Vivero, Israel Cañadas, Ze-Hua Li, Pinar O. Eser, Antja-Voy Hartley, Thomas P. Albertson, Timothy J. Haggerty, Kartika Venugopal, Corinne E. Gustafson, Tran C. Thai, Saemi Han, Arrien A. Bertram, Minh Ha, Ha V. Vo, Ari Zlota, Anna M. Lee-Hassett, Pieter J. Schol, Tetsuo Tani, Navin R. Mahadevan, Erin Shannon, Cameron M. Messier, Bonje Obua, Nathaniel Spicer, Brandon Piel, Minyue Chen, Brittany Meisenheimer, Moataz Noureddine, Ismail Ozgenc, Matthew A. Booker, Patrick H. Lizotte, Marco Campisi, Mubin Tarannum, Elena V. Ivanova, Erik H. Knelson
Activation of the stimulator of interferon genes (STING) pathway promotes antitumor immunity but STING agonists have yet to achieve clinical success. Increased understanding of the mechanism of action of STING agonists in human tumors is key to devel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34335b05bd2da45a66fc885095d546f7
https://doi.org/10.1158/2326-6066.c.6550907
https://doi.org/10.1158/2326-6066.c.6550907
Autor:
David A. Barbie, Raphael Bueno, Cloud P. Paweletz, Rizwan Romee, Michael Y. Tolstorukov, Juan J. Miret, Pasi A. Jänne, Eric L. Smith, Neil Lineberry, Alexander Parent, Richard C. Gregory, Vicky A. Appleman, Adnan O. Abu-Yousif, William G. Richards, Assunta De Rienzo, Marina Vivero, Israel Cañadas, Ze-Hua Li, Pinar O. Eser, Antja-Voy Hartley, Thomas P. Albertson, Timothy J. Haggerty, Kartika Venugopal, Corinne E. Gustafson, Tran C. Thai, Saemi Han, Arrien A. Bertram, Minh Ha, Ha V. Vo, Ari Zlota, Anna M. Lee-Hassett, Pieter J. Schol, Tetsuo Tani, Navin R. Mahadevan, Erin Shannon, Cameron M. Messier, Bonje Obua, Nathaniel Spicer, Brandon Piel, Minyue Chen, Brittany Meisenheimer, Moataz Noureddine, Ismail Ozgenc, Matthew A. Booker, Patrick H. Lizotte, Marco Campisi, Mubin Tarannum, Elena V. Ivanova, Erik H. Knelson
Supplementary Data from Activation of Tumor-Cell STING Primes NK-Cell Therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a5f553fda34db80adc5399773dc6ed3
https://doi.org/10.1158/2326-6066.22545320.v1
https://doi.org/10.1158/2326-6066.22545320.v1
Autor:
Pasi A. Jänne, Prafulla C. Gokhale, Cloud P. Paweletz, Yang Qiu, Yasuki Kamai, Yoshinobu Shiose, Channing Yu, Paul T. Kirschmeier, Mari Kuraguchi, Luke J. Taus, Anika E. Adeni, Emily S. Chambers, Brittaney A. Leeper, Arrien A. Bertram, Elena V. Ivanova, Yutong Zhao, Kenneth Ngo, Tyler J. Teceno, Qing Zeng, Man Xu, Pinar O. Eser, Jens Köhler, Timothy Lopez, Heidi M. Haikala
Summary of EGFR inhibitor resistant patient-derived xenografts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dd2632c75c91725e2f6874eb406951b
https://doi.org/10.1158/0008-5472.22430896
https://doi.org/10.1158/0008-5472.22430896
Autor:
Pasi A. Jänne, Prafulla C. Gokhale, Cloud P. Paweletz, Yang Qiu, Yasuki Kamai, Yoshinobu Shiose, Channing Yu, Paul T. Kirschmeier, Mari Kuraguchi, Luke J. Taus, Anika E. Adeni, Emily S. Chambers, Brittaney A. Leeper, Arrien A. Bertram, Elena V. Ivanova, Yutong Zhao, Kenneth Ngo, Tyler J. Teceno, Qing Zeng, Man Xu, Pinar O. Eser, Jens Köhler, Timothy Lopez, Heidi M. Haikala
Antibodies used in the study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac72ec6a0f9e1a1e4e15284228d95e18
https://doi.org/10.1158/0008-5472.22430899
https://doi.org/10.1158/0008-5472.22430899
Autor:
Pasi A. Jänne, Prafulla C. Gokhale, Cloud P. Paweletz, Yang Qiu, Yasuki Kamai, Yoshinobu Shiose, Channing Yu, Paul T. Kirschmeier, Mari Kuraguchi, Luke J. Taus, Anika E. Adeni, Emily S. Chambers, Brittaney A. Leeper, Arrien A. Bertram, Elena V. Ivanova, Yutong Zhao, Kenneth Ngo, Tyler J. Teceno, Qing Zeng, Man Xu, Pinar O. Eser, Jens Köhler, Timothy Lopez, Heidi M. Haikala
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) are the standard-of-care treatment for EGFR-mutant non–small cell lung cancers (NSCLC). However, most patients develop acquired drug resistance to EGFR TKIs. HER3 is a unique
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::65c6eaa7ce0560288d418189210ac24c
https://doi.org/10.1158/0008-5472.c.6513742.v1
https://doi.org/10.1158/0008-5472.c.6513742.v1
Autor:
Pasi A. Jänne, Prafulla C. Gokhale, Cloud P. Paweletz, Yang Qiu, Yasuki Kamai, Yoshinobu Shiose, Channing Yu, Paul T. Kirschmeier, Mari Kuraguchi, Luke J. Taus, Anika E. Adeni, Emily S. Chambers, Brittaney A. Leeper, Arrien A. Bertram, Elena V. Ivanova, Yutong Zhao, Kenneth Ngo, Tyler J. Teceno, Qing Zeng, Man Xu, Pinar O. Eser, Jens Köhler, Timothy Lopez, Heidi M. Haikala
Allelic Frequencies in PC-9 vs PC-9 T790M/C797S cells.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a816d548e9eae66b9e70111963fd67a4
https://doi.org/10.1158/0008-5472.22430893
https://doi.org/10.1158/0008-5472.22430893
Autor:
Pasi A. Jänne, Prafulla C. Gokhale, Cloud P. Paweletz, Yang Qiu, Yasuki Kamai, Yoshinobu Shiose, Channing Yu, Paul T. Kirschmeier, Mari Kuraguchi, Luke J. Taus, Anika E. Adeni, Emily S. Chambers, Brittaney A. Leeper, Arrien A. Bertram, Elena V. Ivanova, Yutong Zhao, Kenneth Ngo, Tyler J. Teceno, Qing Zeng, Man Xu, Pinar O. Eser, Jens Köhler, Timothy Lopez, Heidi M. Haikala
Supplementary Figures and legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bf55805d887432d7c9a7ba07c91eb54
https://doi.org/10.1158/0008-5472.22430902.v1
https://doi.org/10.1158/0008-5472.22430902.v1
Autor:
Man Xu, Tyler Teceno, Pasi A. Jänne, Anika E. Adeni, Paul Kirschmeier, Timothy Lopez, Jens Köhler, Emily S. Chambers, Brittaney A Leeper, Mari Kuraguchi, Elena Ivanova, Arrien A. Bertram, Cloud P. Paweletz, Yoshinobu Shiose, Yutong Zhao, C. Yu, Yasuki Kamai, Luke J. Taus, Kenneth H. Ngo, Qing Zeng, Prafulla C. Gokhale, Heidi M. Haikala, Yang Qiu, Pinar O. Eser
Publikováno v:
Cancer Research. 82:130-141
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) are the standard-of-care treatment for EGFR-mutant non–small cell lung cancers (NSCLC). However, most patients develop acquired drug resistance to EGFR TKIs. HER3 is a unique
Autor:
Erik H. Knelson, Elena V. Ivanova, Mubin Tarannum, Marco Campisi, Patrick H. Lizotte, Matthew A. Booker, Ismail Ozgenc, Moataz Noureddine, Brittany Meisenheimer, Minyue Chen, Brandon Piel, Nathaniel Spicer, Bonje Obua, Cameron M. Messier, Erin Shannon, Navin R. Mahadevan, Tetsuo Tani, Pieter J. Schol, Anna M. Lee-Hassett, Ari Zlota, Ha V. Vo, Minh Ha, Arrien A. Bertram, Saemi Han, Tran C. Thai, Corinne E. Gustafson, Kartika Venugopal, Timothy J. Haggerty, Thomas P. Albertson, Antja-Voy Hartley, Pinar O. Eser, Ze-Hua Li, Israel Cañadas, Marina Vivero, Assunta De Rienzo, William G. Richards, Adnan O. Abu-Yousif, Vicky A. Appleman, Richard C. Gregory, Alexander Parent, Neil Lineberry, Eric L. Smith, Pasi A. Jänne, Juan J. Miret, Michael Y. Tolstorukov, Rizwan Romee, Cloud P. Paweletz, Raphael Bueno, David A. Barbie
Publikováno v:
Cancer Immunol Res
Activation of the stimulator of interferon genes (STING) pathway promotes antitumor immunity but STING agonists have yet to achieve clinical success. Increased understanding of the mechanism of action of STING agonists in human tumors is key to devel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59405d3838890ae4cd6be2b194ac5280
https://europepmc.org/articles/PMC9357206/
https://europepmc.org/articles/PMC9357206/
Autor:
Pinar O. Eser, Yang Qiu, Jens Köhler, Yoshinobu Shiose, Timothy Lopez, Prafulla C. Gokhale, C. Yu, Man Xu, Heidi M. Haikala, Pasi A. Jänne
Publikováno v:
Cancer Research. 80:5192-5192
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI) have changed the treatment landscape for EGFR-mutant non-small cell lung cancers (NSCLC); however, most patients develop resistance over time. HER3 is a unique pseudokinase memb